MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-10-0013246
Larmark Pharmaceutical Private Limited - pharma in South 24 Parganas, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.05 Cr
▼ 40% YoY
Net profit · FY 2025
₹2.17 Lakh
Net margin 2.1%
EBITDA · FY 2025
₹9.77 Lakh
EBITDA margin 9.3%
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹40 Lakh
Issued & subscribed
Open charges
₹1.29 Cr
Secured borrowings
Company age
16 yrs
Est. 2010
Employees · EPFO
30
Provident fund records
About Larmark Pharmaceutical Private Limited
Data last updated:
Larmark Pharmaceutical Private Limited is a private limited company based in South 24 Parganas, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 May 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U74900WB2010PTC149728. Its GSTIN is 19AABCL8062D1ZJ (West Bengal).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It was formerly known as La- Marck Pharmaceutical Private Limited. It is led by directors including Moinak Basu and Biswa Nath Pal.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at South 24 Parganas, West Bengal.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.05 Cr, a decline of 40% compared to the previous year. For the same year it recorded a net profit of ₹2.17 Lakh (net margin 2.1%) and EBITDA of ₹9.77 Lakh (EBITDA margin 9.3%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years and 12% over five years.
The company has about 30 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.29 Cr on record.
Larmark Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0013246). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website larmarkpharma.com.
Company details
CIN U74900WB2010PTC149728
Registration Number 149728
Incorporation Date 27 May 2010
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-10-0013246
Recognitions & Rankings of Larmark Pharmaceutical
Contact details
Larmark Pharmaceutical Private Limited's registered office is in South 24 Parganas, West Bengal. Its website is larmarkpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address18/2 Pranabananda Road Ground Floor, Ward No. 110. P.O Garia P.S Patuli, South 24 Parganas, West Bengal, India – 700084
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Larmark Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Larmark Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Larmark Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Larmark Pharmaceutical Private Limited, buy the company report.
Financials of Larmark Pharmaceutical Private Limited
FY 2025 filings availableLarmark Pharmaceutical Private Limited reported revenue of ₹1.05 Cr (down 40% YoY) for FY 2025.
Revenue · FY 2025
₹1.05 Cr ▼ 40%
Net profit · FY 2025
₹2.17 Lakh margin 2.1%
EBITDA · FY 2025
₹9.77 Lakh margin 9.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 40%
3 years · compounded
▼ 19%
5 years · compounded
▼ 12%
EBITDA CAGR growth
1 year
▼ 24%
3 years · compounded
▲ 1%
5 years · compounded
▲ 25%
Revenue has declined at a compounded annual rate (CAGR) of 12% over five years, including a 40% fall in the latest year. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.77 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.17 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.3% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Larmark Pharmaceutical Private Limited, buy the company report.
Board of directors of Larmark Pharmaceutical Private Limited
Larmark Pharmaceutical has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Moinak Basu | Director | 12 Apr 2016 | 10 Years 6 Months | Current |
| Biswa Nath Pal | Director | 20 Jan 2018 | 8 Years 9 Months | Current |
| Chaitali Basu | Director | 03 Aug 2022 | 4 Years 2 Months | Current |
| Samarendra Kumar Basu | Additional Director | 02 Nov 2023 | 2 Years 11 Months | Current |
| Parna Saha Basu | Additional Director | 28 Dec 2023 | 2 Years 10 Months | Current |
| Maitree Basu | Additional Director | 28 Dec 2023 | 2 Years 10 Months | Current |
Auditor
Larmark Pharmaceutical Private Limited is audited by SUJIT GHOSH & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUJIT GHOSH & CO | FY 2023 | 327306E |
Shareholding
The shareholding of Larmark Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Larmark Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.29 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Feb 2024 | 100876133 | Axis Bank Limited | ₹8 Lakh | Open | |
| 20 Sep 2023 | 100821068 | Axis Bank Limited | ₹36 Lakh | Open | |
| 20 Aug 2022 | 100698374 | Hdfc Bank Limited | ₹60 Lakh | Open | |
| 26 Sep 2011 | 10313120 | Bank of India | ₹25 Lakh | Open |
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Larmark Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Larmark Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Larmark Pharmaceutical Private Limited has a workforce of 30 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
30
Active EPFO establishments
1
Employee growth
3.45%
GST
Larmark Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCL8062D1ZJ | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Larmark Pharmaceutical Private Limited, buy the company report.
Recent activity
Larmark Pharmaceutical Private Limited has 10 board changes on record since 2010: 8 appointments and 2 cessations. The latest: Maitree Basu was appointed as Additional Director on 28 Dec 2023.
AGM
Larmark Pharmaceutical Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Filing
Larmark Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Charges
A charge with Axis Bank Limited amounted to Rs. 8.00 Lakh with Charge ID 100876133 was registered on 23 Feb 2024.
Appointed
Maitree Basu was appointed as Additional Director.
Appointed
Parna Saha Basu was appointed as Additional Director.
Appointed
Samarendra Kumar Basu was appointed as Additional Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 36.00 Lakh with Charge ID 100821068 was registered on 20 Sep 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 60.00 Lakh with Charge ID 100698374 was registered on 20 Aug 2022.
Appointed
Chaitali Basu was appointed as Director.
Ceased
Ranendra Kumar Bose ceased to be Director.
Ceased
Dwipendra Kumar Bose ceased to be Director.
Appointed
Biswa Nath Pal was appointed as Director.
5 earlier events are in the company report.
Frequently asked questions
Larmark Pharmaceutical is an active private limited company based in South 24 Parganas, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 May 2010 (16+ years old) and is registered under CIN U74900WB2010PTC149728.
Larmark Pharmaceutical has 6 current directors:
- Moinak Basu - Director
- Biswa Nath Pal - Director
- Chaitali Basu - Director
- Samarendra Kumar Basu - Additional Director
- Parna Saha Basu - Additional Director
- Maitree Basu - Additional Director
The latest financial statements of Larmark Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Larmark Pharmaceutical is 19AABCL8062D1ZJ, registered in West Bengal.
The CIN (Corporate Identification Number) of Larmark Pharmaceutical is U74900WB2010PTC149728. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Larmark Pharmaceutical was incorporated on 27 May 2010, making it 16+ years old. It is registered with the Registrar of Companies, Kolkata.
Maitree Basu was appointed as Additional Director on 28 Dec 2023. Parna Saha Basu was appointed as Additional Director on 28 Dec 2023. Samarendra Kumar Basu was appointed as Additional Director on 02 Nov 2023. Larmark Pharmaceutical has 10 board changes on record in total.
Yes, Larmark Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-10-0013246).
Larmark Pharmaceutical can be reached through the website larmarkpharma.com. Its registered office is in South 24 Parganas, West Bengal, India.
The registered office of Larmark Pharmaceutical is at 182 Pranabananda Road Ground Floor, Ward No. 110. P.O Garia P.S Patuli, South 24 Parganas, West Bengal, India – 700084.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages